Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 745, doi. 10.1007/s10741-021-10208-4
- By:
- Publication type:
- Article
Works matching IS 13824147 AND DT 2023 AND VI 28 AND IP 3
Results: 15
1
2
Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 627, doi. 10.1007/s10741-022-10271-5
- By:
- Publication type:
- Article
3
Effects of SGLT2 inhibitors on cardiac structure and function.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 697, doi. 10.1007/s10741-022-10256-4
- By:
- Publication type:
- Article
4
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 585, doi. 10.1007/s10741-022-10238-6
- By:
- Publication type:
- Article
5
Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 723, doi. 10.1007/s10741-021-10211-9
- By:
- Publication type:
- Article
6
Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 607, doi. 10.1007/s10741-021-10203-9
- By:
- Publication type:
- Article
7
An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 573, doi. 10.1007/s10741-021-10202-w
- By:
- Publication type:
- Article
8
Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 597, doi. 10.1007/s10741-021-10200-y
- By:
- Publication type:
- Article
9
Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 645, doi. 10.1007/s10741-021-10194-7
- By:
- Publication type:
- Article
10
Prognostic impact of diabetes in chronic and acute heart failure.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 577, doi. 10.1007/s10741-021-10193-8
- By:
- Publication type:
- Article
11
Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fraction.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 657, doi. 10.1007/s10741-021-10189-4
- By:
- Publication type:
- Article
12
Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 683, doi. 10.1007/s10741-021-10186-7
- By:
- Publication type:
- Article
13
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 667, doi. 10.1007/s10741-021-10182-x
- By:
- Publication type:
- Article
14
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 709, doi. 10.1007/s10741-021-10170-1
- By:
- Publication type:
- Article
15
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients.
- Published in:
- Heart Failure Reviews, 2023, v. 28, n. 3, p. 733, doi. 10.1007/s10741-021-10157-y
- By:
- Publication type:
- Article